Category: Medical Plans

Mikhail Blagosklonny Article

Mikhail Blagosklonny Scientific Researcher–Professor and Proponent of a Cancer-Free Society.Mikhail Blagosklonny is a scientist studying cancer and aging who formulated a hypothesis involving both with TOR signaling. He has had a distinguished as a scientist, professor, writer and editor-in-chief with a focus on cancer treatments, cures and anti-aging in the prevention of aging illness and disease. Mr. Blagosklonny believes that one day people can be cancer free and has focused his research and teaching in this direction.

Writing and Publications

Mr. Blangsklonny is top in his field of study and as a professor that has made one of his goals to bring awareness to the medical community during his career. He has written numerous publications in his field of science, cancer, and aging. Dr. Blangslonny currently has about 270 peers reviewed publications with over 25,000 citations that have brought awareness to his medical and scientific research findings. One of the other things Mikhail Blagosklonny known for is his seat as editor-in-chief of the Onctarget, Cell Cycle, and other publications.

Education and Degrees

Mr. Mikhail Blagosklonny attended college in Russia earning his medical degrees at the University of St. Petersburg, Russia. Mikhail Blagosklonny earned an M.D. degree in internal medicine. He then went on to earn a Ph.D. in experimental medicine and cardiology at the same University.

Employment Positions

Mikhail Blagosklonny has taken positions in both the teaching and scientific settings. He took a position at the New York Medical College in Valhalla, New York in 2002. At this college the position Mr. Blagosklonny held was an associate professor of medicine. In another position the doctor worked in a position with the title of senior scientist. This position was held at Ordway Research Institute, Albany New York. Afterward in 2009 he went to work for Roswell Park Cancer Institute. He was appointed to hold the title professor of oncology at the Roswell Institute.

Scientific Research

Through his scientific research that was focused on cancer and aging he believes rapamycin is important. The drug is an anti-cancer drug with properties that also helps with anti-aging and it showed proof it could slow tumor growth. He considers rapamycin to be a drug that could extend life. As another focus of his scientific research, he studied the mechanisms of aging, which helped show how this drug may be beneficial. After taking the position at Roswell Park Cancer Institute he claimed he would be teaching the new generation of future cancer researchers. However what he studied in his position as a scientist helped to develop cancer drugs and non-genotoxic compounds to suppress aging diseases.During his career in teaching positions, writing and scientific research it has included molecular biology, cellular biology, cell cycle, anti-cancer therapeutics, tumor suppressors and clinical investigations. In this research, Mr. Blagosklonny formed the hypothesis that shows a potential connection with TOR signaling. This signaling is within aging and cancer along with the use of anti-cancer drugs like rapamycin.

InnovaCare Health Enters A New Season Of Hiring To Further Boost Performance

InnovaCare Health is among physician practice services providers across the U.S. that have come up with customized approaches to serving customers. The company has been applauded for introducing new technology in the provision of services to their customers. Unlike before, it now takes few minutes to serve one customer and they have seen an increase in the number of subscribers for different services.

With great performance and a promising future, InnovaCare Health has invested in the upgrading of its network. All the sections of the company are integrated through a strong network that ensures the delivery of services is a continuous process that does not bar the execution of duties. One can also send requests for certain services remotely and the professionals tasked with handling different duties will prepare the required information in time.

Visit the company website at for more information.

One of the challenges InnovaCare had to deal with when the company invested in new technology was training their employees on how to use the system. Currently, all workers are familiar with the system and can serve as many customers as possible. Some of the programs of InnovaCare that have seen an increase in users include Medicaid and Medicare, which have more than 250,000 subscribers.

Hiring new executives
To make the implementation of different plans possible and timely, InnovaCare Health has hired new executives, who are experienced and knowledgeable on different matters. The first professional who was appointed to the company is Jonathan Meyers on, who holds an executive position as the head of actuaries. Jonathan will be a big asset to InnovaCare Health since he previously worked in the Medicaid and Medicare programs.

Mike Sortino, an accountant whose professional career is a reflection of dedication and the zeal to grow, was hired to fill the chief accountant’s office. Mike boasts of experience spanning over 20 years and he worked with established companies like HCC Specialty.

About the managers
One cannot mention the achievements InnovaCare Health has made without acknowledging the effort the management team has put to the company. Dr. Richard Shinto, the current President and Chief Executive Officer of InnovaCare Health, is one of the leaders who have overseen the growth process of the company.

Rick Shinto sits in a council that drafts the strategies the company uses to push for the development of a strong system. With support from the Chief Administrative Officer, Penelope Kokkinides, he has elevated InnovaCare Health from a struggling state to the current strong position the company holds.